Skip to content
Home/Companies/Biotech/NeoPhore

NeoPhore

Biotech·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns NeoPhore?

NeoPhore is currently owned by Neva SGR through Neva First (2020 vintage), since 2024. Across its history, NeoPhore has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-23

Neva SGR
Most recent investor
Neva SGR
Neva First · 2020 · VC
3 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Claris Ventures SGR, LIFTT and Neva SGR since 2021.
Co-invest · 3 holders · 2021 · present
Claris Ventures SGR
Claris Ventures SGRActive
2021 · present(5yr) · Claris Biotech I · 2020 · Life Sciences VC
LIFTT
LIFTTActive
2023 · present(3yr) · LIFTT · 2019 · VC
Neva SGR
Neva SGRActive
2024 · present(2yr) · Neva First · 2020 · VC

More from Neva First

Other portfolio companies in the same fund.

AAVantgarde Bio
Active
BiotechItaly· 2025
Caracol
Caracol
Active
IndustrialsItaly· 2023
CoreTigo
CoreTigo
Active
IndustrialsIsrael· 2023
Energy Dome
Energy Dome
Active
ClimateTechItaly· 2023
Hazy
Exited 2024
Data & AnalyticsUK· 2023
to SAS
Leaf Space
Leaf Space
Active
Aerospace & DefenceItaly· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue